These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Conformational analysis of a highly potent dicyclic gonadotropin-releasing hormone antagonist by nuclear magnetic resonance and molecular dynamics. Bienstock RJ; Rizo J; Koerber SC; Rivier JE; Hagler AT; Gierasch LM J Med Chem; 1993 Oct; 36(22):3265-73. PubMed ID: 8230116 [TBL] [Abstract][Full Text] [Related]
6. NMR studies on the structure of some cyclic and linear antagonists of luteinizing hormone-releasing hormone (LHRH). Reddy DV; Jagannadh B; Dutta AS; Kunwar AC Int J Pept Protein Res; 1995 Jul; 46(1):9-17. PubMed ID: 7558603 [TBL] [Abstract][Full Text] [Related]
7. Computer simulation of the free energy of peptides with the local states method: analogues of gonadotropin releasing hormone in the random coil and stable states. Meirovitch H; Koerber SC; Rivier JE; Hagler AT Biopolymers; 1994 Jul; 34(7):815-39. PubMed ID: 8054467 [TBL] [Abstract][Full Text] [Related]
8. Relative potencies of antagonists of the luteinizing hormone releasing hormone with Lys8 and Arg8 and substitutions in positions 3, 5, 6, 7 and 8. Folkers K; Bowers C; Tang PF; Kobota M; Xiao SB; Bender W; Liu YZ Z Naturforsch C J Biosci; 1986; 41(11-12):1087-91. PubMed ID: 2437717 [TBL] [Abstract][Full Text] [Related]
9. Effects of C alpha-methyl substitution on the conformation of linear GnRH antagonist analogs. Liff MI; Kopple KD; Tian Z; Roeske RW Int J Pept Protein Res; 1994 May; 43(5):471-6. PubMed ID: 8070971 [TBL] [Abstract][Full Text] [Related]
10. Increased potency of antagonists of the luteinizing hormone releasing hormone which have D-3-Pal in position 6. Folkers K; Bowers C; Xiao SB; Tang PF; Kubota M Biochem Biophys Res Commun; 1986 Jun; 137(2):709-15. PubMed ID: 2425802 [TBL] [Abstract][Full Text] [Related]
11. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin. Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985 [TBL] [Abstract][Full Text] [Related]
12. Theoretical conformational analysis of the opioid delta antagonist H-Tyr-Tic-Phe-OH and the mu agonist H-Tyr-D-Tic-Phe-NH2. Wilkes BC; Schiller PW Biopolymers; 1994 Sep; 34(9):1213-9. PubMed ID: 7948733 [TBL] [Abstract][Full Text] [Related]
13. Conformation-function relationships in LHRH analogs. I. Conformations of LHRH peptide backbone. Nikiforovich GV; Marshall GR Int J Pept Protein Res; 1993 Aug; 42(2):171-80. PubMed ID: 8407111 [TBL] [Abstract][Full Text] [Related]
14. Constrained phenylalanine analogues. Preferred conformation of the 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid (Tic) residue. Valle G; Kazmierski WM; Crisma M; Bonora GM; Toniolo C; Hruby VJ Int J Pept Protein Res; 1992; 40(3-4):222-32. PubMed ID: 1335996 [TBL] [Abstract][Full Text] [Related]
15. Decreased histamine release by luteinizing hormone-releasing hormone antagonists obtained upon translocation of the cationic amino acid from position 8 to position 7. Flouret G; Mahan K; Majewski T J Med Chem; 1992 Feb; 35(4):636-40. PubMed ID: 1371810 [TBL] [Abstract][Full Text] [Related]
16. Solution and solid-state structure of the diketopiperazine of tyrosyl-tetrahydroisoquinoline-3-carboxylic acid. Ciajolo MR; Balboni G; Picone D; Salvadori S; Tancredi T; Temussi PA; Tuzi A Int J Pept Protein Res; 1995 Aug; 46(2):134-8. PubMed ID: 8567167 [TBL] [Abstract][Full Text] [Related]